66 Longitudinal effects of elexacaftor-tezacaftor-ivacaftor therapy on airway infection and inflammation in people with cystic fibrosis

Autor: Schaupp, L., Addante, A., Voller, M., Fentker, K., Bardua, M., Kuppe, A., Duerr, J., Piehler, L., Rohmel, J., Thee, S., Kirchner, M., Ziehm, M., Lauster, D., Haag, R., Gradzielski, M., Stahl, M., Mertins, P., Boutin, S., Graeber, S., Mall, M.
Zdroj: In Journal of Cystic Fibrosis October 2023 22 Supplement 3:S35-S35
Databáze: ScienceDirect